Detalhe da pesquisa
1.
Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
Clin Infect Dis
; 75(11): 1971-1979, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438137
2.
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).
Expert Rev Vaccines
; 23(1): 213-225, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288980
3.
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).
Expert Rev Vaccines
; 22(1): 288-298, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883371